Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening

Journal of Urology

Volumn 163, Issue 2, 2000, Pages 503-510

  Merrill, Ray M ^a,b   Stephenson, Robert A ^a,c  

^a University of Utah College of Medicine ^*

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Mortality; Prostate specific antigen; Prostatic neoplasms; SEER program

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RACE; SECOND CANCER;

EID: 0033966312     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67912-8     Document Type: Article

References (22)

1. Extramural Committee to Assess Measures of Progress Against Cancer: Measurement of progress against cancer. J Natl Cancer Inst, 82: 825, 1990
2. Bailar, J. C., III and Gornick, H. L.: Cancer undefeated. N Engl J Med, 336: 1569, 1997
3. Kramer, B. S. and Klausner, R. D.: Grappling with cancer - defeatism versus the reality of progress. N Engl J Med, 337: 931, 1997
4. Feuer, E. J., Merrill, R. M. and Hankey, B. F.: Cancer surveillance series: interpreting trends in prostate cancer - part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst, 91: 1025, 1999
5. Breslow, N., Chan, C. W., Dhom, G. et al: Latent carcinoma of the prostate at autopsy in seven areas. Int J Cancer, 20: 680, 1977
6. Carter, H. B., Piantadosi, S. and Isaacs, J. T.: Clinical evidence for and implications of the multistep development of prostate cancer. J Urol, 143: 742, 1990
7. Catalona, W. J., Smith, D. S., Ratliff, T. L. et al: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med, 324: 1156, 1991.
8. Legler, J. M., Feuer, E. J., Potosky, A. L. et al: The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control, 9: 519, 1998
9. Landis, S. H., Murray, T., Bolden, S. et al: Cancer statistics, 1999. CA Cancer J Clin, 49: 8, 1999
10. Ries, L. A. G., Kosary, C. L. and Hankey, B. F.: SEER Cancer Statistics Review, 1973-1996. Bethesda: National Cancer Institute, 1999
11. National Cancer Institute Online: Prevalence from the Applied Research Branch Cancer Statistics. Available from http://www. dccps.ims.nci.nih.gov/ARB/Prevalence via the INTERNET. Accessed April 28, 1999
12. Merrill, R. M. and Brawley, O. W.: Prostate cancer incidence and mortality rates among white and black men. Epidemiology, 8: 126, 1997
13. Chu, K. C., Miller, B. A., Feuer, E. J. et al: A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol, 47: 1451, 1994
14. International Classification of Diseases, 9th Revision, Clinical Modification, 4th ed. Department of Health and Human Services Publication No. 91-1260. Washington, D. C.: United States Departments of Health and Human Services, and Public Health Service, and the Health Care Financing Administration, 1991
15. Barry, M. J.: Natural history of clinically localized prostate cancer. Semin Surg Oncol, 11: 3, 1995
16. Bostwick, D. G.: Grading prostate cancer. Am J Clin Pathol, suppl., 102: S38, 1994
17. Etzioni, R., Legler, J. M., Feuer, E. J. et al: Cancer surveillance series: interpreting trends in prostate cancer - part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst, 91: 1033, 1999
18. Stanford, J. L., Stephenson, R. A., Coyle, L. M. et al: Prostate Cancer Trends 1973-1995. SEER Program. National Institutes of Health Publication No. 243465. Bethesda: National Cancer Institute, 1998
19. Bostwick, D. G.: Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol, 18: 796, 1994
20. Fleshner, N. E., Cookson, M. S., Soloway, S. M. et al: Repeat transrectal ultrasound-guided prostate biopsy: a strategy to improve the reliability of needle biopsy grading in patients with well-differentiated prostate cancer. Urology, 52: 659, 1998
21. Catalona, W. J. and Bigg, S. W.: Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol, 143: 538, 1990
22. Merrill, R. M.: Changes in the use of radical prostatectomy for treating prostate cancer in the USA. Lancet, 348: 963, 1996